Position in NVO
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$3,557,627
+$601,531 QoQ
Shares Held
74,210
-7.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#269
of 1,348 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Third View Private Wealth, LLC holds $19,572,460 across 9 Drug Manufacturers - General names. NVO ranks #3 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,404 | $4,420,093 | |
| 2 | NVS |
Novartis AG
|
22,936 | $3,594,529 | |
| 3 | NVO |
Novo Nordisk A S
This page
|
74,210 | $3,557,627 | |
| 4 | AZN |
Astrazeneca PLC
|
16,205 | $3,072,792 | |
| 5 | LLY |
ELI LILLY & Co
|
1,938 | $2,324,495 | |
| 6 | ABBV |
AbbVie Inc.
|
4,300 | $1,082,052 | |
| 7 | MRK |
Merck & Co., Inc.
|
5,509 | $707,906 | |
| 8 | AMGN |
Amgen Inc
|
1,180 | $427,301 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,557,627 | 74,210 | Shares | Other | 2026-07-27 | |
| 2026-03-31 | $2,956,096 | 80,438 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $3,565,416 | 70,075 | Shares | Other | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||